Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jef Debrabander
Ut Southwestern Medical Center, Department: Biochemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
Revolution Medicines
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
Chemical and Biological Optimization of a Gram negative Selective Antibiotic
This application proposes the synthesis and biological evaluation of the novel macrolide antibiotic Mangrolide A, a new Gram-selective antibiotic with aminoglycoside mode-of- action. Our combined chemical and biological approach aims to provide a collection of mangrolide-based leads for Gram-negative pneumonal infections. The proposed research is highly relevant because of hospital-acquired pneumonia caused by drug- resistant Gram-negative pathogens.
Filed on March 08, 2016.
Tell us what you know about Jef Debrabander's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Jef Debrabander”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jef Debrabander | Ut Southwestern Medical Center | Conflict of Interest | Revolution Medicines | $0 - $4,999 |
| Jef Debrabander | Ut Southwestern Medical Center | Conflict of Interest | Revolution Medicines | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.